Is Biogen’s Research Pipeline a Reason to Invest?
Biogen Inc. (NASDAQ:BIIB) has been a laggard this year with its share price plunging 41% year-to-date against the broader market’s 26.6% gain. The …
Biogen Inc
Where Will Biogen Stock Be In 5 Years?
Biogen Inc. (NASDAQ:BIIB) has been a leading biotechnology firm since its founding in 1978 when it made important progress in treating complex illnesses. It …
Regeneron Pharma Stock Forecast
Regeneron Pharma Stock Forecast: Despite centuries of progress in medicine – and a collection of high-impact advances in the past 50 years – …